Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Australasian Leukaemia and Lymphoma Group
National Institute of Allergy and Infectious Diseases (NIAID)
Gruppo Italiano Malattie EMatologiche dell'Adulto
Swiss Cancer Institute
University of Miami
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Trans Tasman Radiation Oncology Group
National Cancer Institute (NCI)
St. Jude Children's Research Hospital